Document is current
Any future updates will be listed below
-
Authors
Yang, Lijiao
Ye, Nan
Wang, Guoqin
Bian, Weijing
Xu, Fengbo
Zhao, Dong
Liu, Jing
Hao, Yongchen
Liu, Jun
Yang, Na
Cheng, Hong https://orcid.org/0000-0002-7908-3333
,
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02306616 at ClinicalTrials.govDocuments that mention this clinical trial
Interactions of ST-elevation myocardial infarction, age, and sex and the risk of major adverse cardiovascular events among Chinese adults: a secondary analysis of a single-centre prospective cohort
https://doi.org/10.1136/bmjopen-2021-058494
The association between atrial fibrillation and in-hospital outcomes in chronic kidney disease patients with acute coronary syndrome: findings from the improving care for cardiovascular disease in China-acute coronary syndrome (CCC-ACS) project
https://doi.org/10.1186/s12872-021-02125-z
Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project
https://doi.org/10.1186/s12933-018-0793-x
Rationale and design of the Improving Care for Cardiovascular Disease in China (CCC) project: A national effort to prompt quality enhancement for acute coronary syndrome
https://doi.org/10.1016/j.ahj.2016.06.005
Association between P2Y12 inhibitor reloading and in-hospital outcomes for patients with non-ST-segment elevation acute coronary syndrome already on chronic P2Y12 receptor inhibitors therapy in China: findings from the CCC–ACS (improving care for cardiovascular disease in China-acute coronary syndrome) project
https://doi.org/10.1186/s40001-023-01025-6
-
Funding
Funding for this research was provided by:
American Heart Association
Chinese Society of Cardiology
Pfizer
AstraZeneca
- License Information
-
More Information
Article History
Received: 25 July 2020
Accepted: 11 June 2021
First Online: 17 July 2021
Declarations
:
: Institutional review board approval was granted for the aggregate data set for research and quality improvement by the Ethics Committee of Beijing Anzhen Hospital, Capital Medical University. As this was a large population-based study, approval from the Ethics Committee of Beijing Anzhen Hospital, Capital Medical University, included a waiver of informed consent.
: Not applicable.
: The authors declare that they have no competing interests.
